Endothelial progenitor cells derived from wharton's jelly of human umbilical cord attenuate ischemic acute kidney injury by increasing vascularization and decreasing apoptosis, inflammation, and fibrosis

Cell Transplantation

Volumn 24, Issue 7, 2015, Pages 1363-1377

  Liang, Chan Jung ^a,b   Shen, Wen Ching ^a   Chang, Fu Bin ^a   Wu, Vin Cent ^c   Wang, Shu Huei ^a   Young, Guang Huar ^c   Tsai, Jaw Shiun ^c   Tseng, Ying Chin ^d   Peng, Yu Sen ^e   Chen, Yuh Lien ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d CATHAY GENERAL HOSPITAL   (Taiwan)

^e FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Acute kidney injury (AKI); Angiogenesis; Apoptosis; Endothelial progenitor cells (EPCs); Ischemia

Indexed keywords

CALVASCULIN; CHEMOKINE; CREATININE; CYTOKINE; MACROPHAGE INFLAMMATORY PROTEIN 2; NITROGEN; REACTIVE OXYGEN METABOLITE; UREA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATTENUATION; BLOOD SAMPLING; CELL CULTURE; CELL DENSITY; CELL ISOLATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIAL PROGENITOR CELL TRANSPLANTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INJECTION; JONES SILVER STAINING; KERATINOCYTE; KIDNEY BLOOD FLOW; KIDNEY CAPSULE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY SCORE; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; KIDNEY TUBULE CELL; MALE; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; STEM CELL TRANSPLANTATION; TUNEL ASSAY; UMBILICAL CORD; UREA NITROGEN BLOOD LEVEL; WHARTON JELLY; ACUTE KIDNEY INJURY; ANIMAL; FIBROSIS; METABOLISM; REPERFUSION INJURY;

MUS;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; ENDOTHELIAL PROGENITOR CELLS; FIBROSIS; HUMANS; INFLAMMATION; MICE; REPERFUSION INJURY; UMBILICAL CORD; WHARTON JELLY;

EID: 84937403998     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368914X681720     Document Type: Article

References (45)

1. Akcay, A.; Nguyen, Q.; Edelstein, C. L. Mediators of inflammation in acute kidney injury. Mediat. Inflamm. 2009:137072; 2009.
2. Alev, C.; Ii, M.; Asahara, T. Endothelial progenitor cells: A novel tool for the therapy of ischemic diseases. Antioxid. Redox. Signal. 15:949-965; 2011.
3. Bajwa, A.; Kinsey, G. R.; Okusa, M. D. Immune mechanisms and novel pharmacological therapies of acute kidney injury. Curr. Drug Targets 10:1196-1204; 2009.
4. Ballard, V. L. T.; Edelberg, J. M. Stem cells and the regeneration of the aging cardiovascular system. Circ. Res. 100:1116-1127; 2007.
5. Basile, D. P. The endothelial cell in ischemic acute kidney injury: Implications for acute and chronic function. Kidney Int. 72:151-156; 2007.
6. Basile, D. P.; Donohoe, D.; Roethe, K.; Osborn, J. L. Renal ischemic injury results in permanent damage to peritubu-lar capillaries and influences long-term function. Am. J. Physiol. Renal Physiol. 281:F887-F899; 2001.
7. Batsali, A. K.; Kastrinaki, M. C.; Papadaki, H. A.; Pontikoglou, C. Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: Biological properties and emerging clinical applications. Curr. Stem Cell Res. Ther. 8:144-155; 2013.
8. Chade, A. R.; Zhu, X.; Lavi, R.; Krier, J. D.; Pislaru, S.; Simari, R. D.; Napoli, C.; Lerman, A.; Lerman, L. O. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation 119:547-557; 2009.
9. Chade, A. R.; Zhu, X. Y.; Krier, J. D.; Jordan, K. L.; Textor, S. C.; Grande, J. P.; Lerman, A.; Lerman, L. O. Endothelial progenitor cells homing and renal repair in experimental renovascular disease. Stem Cells 28:1039-1047; 2010.
10. Conger, J. D.; Schultz, M. F.; Miller, F.; Robinette, J. B. Responses to hemorrhagic arterial pressure reduction in different ischemic renal failure models. Kidney Int. 46:318-323; 1994.
11. Du, T.; Cheng, J.; Zhong, L.; Zhao, X. F.; Zhu, J.; Zhu, Y. J.; Liu, G. H. The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism. Cytotherapy 14:1215-1227; 2012.
12. Fang, T. C.; Pang, C. Y.; Chiu, S. C.; Ding, D. C.; Tsai, R. K. Renoprotective effect of human umbilical cord-derived mesenchymal stem cells in immunodeficient mice suffering from acute kidney injury. PLoS One 7:e46504; 2012.
13. Fukushima, S.; Sawa, Y.; Suzuki, K. Choice of cell-delivery route for successful cell transplantation therapy for the heart. Future Cardiol. 9:215-227; 2013.
14. Fu, Y. S.; Cheng, Y. C.; Lin, M. Y.; Cheng, H.; Chu, P. M.; Chou, S. C.; Shih, Y. H.; Ko, M. H.; Sung, M. S. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: Potential therapeutic application for Parkinsonism. Stem Cells 24:115-124; 2006.
15. Goligorsky, M. S.; Kuo, M. C.; Patschan, D.; Verhaar, M. C. Endothelial progenitor cells in renal disease. Nephrology 14:291-297; 2009.
16. Gupta, S.; Verfaillie, C.; Chmielewski, D.; Kren, S.; Eidman, K.; Connaire, J.; Heremans, Y.; Lund, T.; Blackstad, M.; Jiang, Y.; Luttun, A.; Rosenberg, M. E. Isolation and, characterization of kidney-derived stem cells. J. Am. Soc. Nephrol. 17:3028-3040; 2006.
17. Havasi, A.; Borkan, S. C. Apoptosis and acute kidney injury. Kidney Int. 80:29-40; 2011.
18. Hsieh, J. Y.; Fu, Y. S.; Chang, S. J.; Tsuang, Y. H.; Wang, H. W. Functional module analysis reveals differential osteo-genic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord. Stem Cells Dev. 19:1895-1910;2010.
19. Hynes, B.; Kumar, A. H.; O'Sullivan, J.; Klein Buneker, C.; Leblond, A. L.; Weiss, S.; Schmeckpeper, J.; Martin, K.; Caplice, N. M. Potent endothelial progenitor cell-conditioned media-related anti-apoptotic, cardiotrophic, and pro-angiogenic effects post-myocardial infarction are mediated by insulin-like growth factor-1. Eur. Heart J. 34:782-789; 2013.
20. Kale, S.; Karihaloo, A.; Clark, P. R.; Kashgarian, M., Krause, D. S.; Cantley, L. G. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J. Clin. Invest. 112:42-49; 2003.
21. Kang, D. H.; Kanellis, J.; Hugo, C.; Truong, L.; Anderson, S.; Kerjaschki, D.; Schreiner, G. F.; Johnson, R. J. Role of the microvascular endothelium in progressive renal disease. J. Am. Soc. Nephrol. 13:806-816; 2002.
22. Li, B.; Cohen, A.; Hudson, T. E.; Motlagh, D.; Amrani, D. L.; Duffield, J. S. Mobilized human hematopoietic stem/ progenitor cells promote kidney repair after ischemia/ reperfusion injury. Circulation 121:2211-2220; 2010.
23. Lin, F.; Cordes, K.; Li, L.; Hood, L.; Couser, W. G.; Shankland, S. J.; Igarashi, P. Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J. Am. Soc. Nephrol. 14:1188-1199; 2003.
24. Ma, Y. Y.; Sun, D.; Li, J.; Yin, Z. C. Transplantation of endothelial progenitor cells alleviates renal interstitial fibrosis in a mouse model of unilateral ureteral obstruction. Life Sci. 86:798-807; 2010.
25. Molls, R. R.; Savransky, V.; Liu, M.; Bevans, S.; Mehta, T.; Tuder, R. M.; King, L. S.; Rabb, H. Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury. Am. J. Physiol. Renal Physiol. 290:F1187-F1193; 2006.
26. Morgera, S.; Kraft, A. K.; Siebert, G.; Luft, F. C.; Neumayer, H. H. Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies. Am. J. Kidney Dis. 40:275-279; 2002.
27. Morgera, S.; Schneider, M.; Neumayer, H. H. Long-term outcomes after acute kidney injury. Crit. Care Med. 36:S193-S197; 2008.
28. Mount, P. F.; Gleich, K.; Tam, S.; Fraser, S. A.; Choy, S. W.; Dwyer, K. M.; Lu, B.; Denderen, B. V.; Fingerle- Rowson, G.; Bucala, R.; Kemp, B. E.; Power, D. A. The outcome of renal ischemia-reperfusion injury is unchanged in AMPK-P1 deficient mice. PLoS One 7:e29887; 2012.
29. Patschan, D.; Plotkin, M.; Goligorsky, M. S. Therapeutic use of stem and endothelial progenitor cells in acute renal injury, Ca ira. Curr. Opin. Pharmacol. 6:176-183; 2006.
30. Plotkin, M. D.; Goligorsky, M. S. Mesenchymal cells from adult kidney support angiogenesis and differentiate into multiple interstitial cell types including erythropoietin-producing fibroblasts. Am. J. Physiol Renal Physiol. 291: 902-912; 2006.
31. Reekmans, K. P.; Praet, J.; De Vocht, N.; Tambuyzer, B. R.; Bergwerf, I.; Daans, J.; Baekelandt, V.; Vanhoutte, G.; Goossens, H.; Jorens, P. G.; Ysebaert, D. K.; Chatterjee, S.; Pauwels, P.; Van Marck, E.; Berneman, Z. N.; Van der Linden, A.; Ponsaerts, P. Clinical potential of intravenous neural stem cell delivery for treatment of neuroinflamma-tory disease in mice? Cell Transplant. 20:851-869; 2011.
32. Romanov, Y. A.; Svintsitskaya, V. A.; Smirnov, V. N. Searching for alternative sources of postnatal human mesenchymal stem cells: Candidate MSC-like cells from umbilical cord. Stem Cells 21:105-110; 2003.
33. Sabbahy, M. E.; Vaidya, V. S. Ischemic kidney injury and mechanisms of tissue repair. Wiley Interdiscip. Rev. Syst. Biol. Med. 3:606-618; 2010.
34. Scheubel, R. J.; Zorn, H.; Silber, R. E.; Kuss, O.; Morawietz, H.; Holtz, J.; Simm, A. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J. Am. Coll. Cardiol. 42:2073-2080; 2003.
35. Schiffl, H. Renal recovery from acute tubular necrosis requiring renal replacement therapy: A prospective study in critically ill patients. Nephrol. Dial. Transplant. 21:1248-1252; 2006.
36. Shen, W. C.; Liang, C. J., Wu, V. C.; Wang, S. H.; Young, G. H.; Lai, I. R.; Chien, C. L.; Wang, S. M.; Wu, K. D.; Chen, Y. L. Endothelial progenitor cells derived from Wharton's jelly of the umbilical cord reduces ischemia-induced hind limb injury in diabetic mice by inducing HIF-1a/IL-8 expression. Stem Cells Dev. 22:1408-1418; 2013.
37. Stroo, I.; Stokman, G.; Teske, G. J.; Raven, A.; Butter, L. M.; Florquin, S.; Leemans, J. C. Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase. Int. Immunol. 22:433-442; 2010.
38. Taghizadeh, R. R.; Cetrulo, K. J.; Cetrulo, C. L. Wharton's Jelly stem cells: Future clinical applications. Placenta 32: S311-S315; 2011.
39. Tse, W.; Laughlin, M. Cord blood transplantation in adult patients. Cytotherapy 7:228-242; 2005.
40. Ueda, N.; Kaushal, G. P.; Shah, S. V. Apoptotic mechanisms in acute renal failure. Am. J. Med. 108:403-415; 2000.
41. Wang, H. S.; Hung, S. C.; Peng, S. T.; Huang, C. C.; Wei, H. M.; Guo, Y. J.; Fu, Y. S.; Lai, M. C.; Chen, C. C. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22:1330-1337; 2004.
42. Wang, S. H.; Lin, S. J.; Chen, Y. H.; Lin, F. Y.; Shih, J. C.; Wu, C. C.; Wu, H. L.; Chen, Y. L. Late outgrowth endothe- lial cells derived from Wharton Jelly in human umbilical cord reduce neointimal formation after vascular injury. Arterioscler. Thromb. Vasc. Biol. 29:816-822; 2009.
43. Yang, Z.; von Ballmoos, M. W.; Faessler, D.; Voelzmann, J.; Ortmann, J.; Diehm, N.; Kalka-Moll, W.; Baumgartner, I.; Di Santo, S.; Kalka, C. Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells. Atherosclerosis 211: 103-109; 2010.
44. Yokoo, T.; Kawamura, T.; Kobayashi, E. Stem cells for kidney repair: Useful tool for acute renal failure? Kidney Int. 74:847-849; 2008.
45. Zhang, S.; Han, C. H.; Chen, X. S.; Zhang, M.; Xu, L. M.; Zhang, J. J.; Xia, Q. Transient ureteral obstruction prevents against kidney ischemia/reperfusion injury via hypoxia-inducible factor (HIF)-2 activation. PLoS One 7:e29876; 2012.